Lindsay Helget, MD

University of Nebraska Medical Center
Omaha, NE, United States

Assistant Professor in the Department of Rheumatology, University of Nebraska Medical Center

Disclosure information not submitted.

Presentation(s):

• 1829: Efficacy and Safety of Allopurinol and Febuxostat in Patients with Gout and Chronic Kidney Disease: A Subgroup Analysis of the STOP Gout Study

  Sunday, November 13, 2022
  10:20 AM – 10:25 AM Eastern Time

• 1583: Race and Disease Severity Predict Reduced Response to Treat-to-Target Urate Lowering Therapy in Gout: Post-hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial

  Sunday, November 13, 2022
  4:00 PM – 4:10 PM Eastern Time

• 1829: Efficacy and Safety of Allopurinol and Febuxostat in Patients with Gout and Chronic Kidney Disease: A Subgroup Analysis of the STOP Gout Study

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1797: Factors Driving Opioid Use in United States Veterans with Gout

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1798: Health-Related Quality of Life Improvements Resulting from a Treat-to-Target Strategy in the Management of Gout: Post- Hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time